About Steven
Steve Falcone is the Chief Operating Officer at ElevateBio. Steve brings more than 30 years of operations, quality, and compliance leadership across global biopharmaceutical manufacturing.
Prior to joining ElevateBio, Steve served as Vice President of Quality Complaints, Audit and Inspections, and Quality Intelligence at Novo Nordisk, where he set strategic direction for the company’s global audit, inspection, and complaint programs.
His previous roles include Chief Quality Officer for Brammer Bio (acquired by Thermo Fisher) and VP and Senior Director at Thermo Fisher where he transformed their inspection readiness and external engagement programs, as well as supported creation of new business services for advanced therapies including plasmid, mRNA, cell therapy and regulatory affairs offerings. Prior roles include VP of Quality at Sanofi Genzyme and various quality and operational positions at Amgen, Solstice Neurosciences and Bayer.
Education and Accomplishments
Steve holds a Bachelor of Science in Chemistry from the University of California, Berkeley.
